New antibody design, and Standard lgG antibody design (IMAGE)
Caption
New antibody design, and Standard lgG antibody design. The new designed antibodies might provide more effective treatment methods for Alzheimer’s disease. By designing to bind even to the smaller aggregates, or clumps, of the amyloid-beta protein, it may be possible to check the progress of the disease.
Credit
Fadi Rofo, Uppsala University
Usage Restrictions
to accompany this study or other research by Greta Hultqvist's group.
License
Original content